Harvey, V J <br/><br/>
A randomized phase II study comparing capecitabine alone with capecitabine and oral cyclophosphamide in patients with advanced breast cancer-cyclox II.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  Jul 2013 
 - 1828-1834 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1569-8041 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdt065  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Breast Neoplasms--drug therapy<br/>Capecitabine<br/>Cyclophosphamide--administration & dosage<br/>Deoxycytidine--administration & dosage<br/>Disease-Free Survival<br/>Female<br/>Fluorouracil--administration & dosage<br/>Humans<br/>Liver Neoplasms--drug therapy<br/>Lymphatic Metastasis<br/>Middle Aged<br/>Neutropenia--chemically induced<br/>Treatment Outcome